White & Case advises GVS on acquisition of Shanghai Transfusion Technology
1 min read
Global law firm White & Case LLP has advised GVS S.p.A., a leading provider of advanced filtration solutions, on the acquisition through its fully owned subsidiary GVS Technology (Suzhou) Co., Ltd., of the entire share capital in Shanghai Transfusion Technology Co., Ltd. (STT), a Shanghai-headquartered company active in the production and sale of blood transfusion-related products, from a company controlled by Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
The acquisition, which will be financed entirely by GVS’s own funds, involves an upfront payment for the acquisition of STT's share capital and a deferred payment if STT obtains authorization to produce and market a new strategic product line. In addition, immediately after closing, STT will repay a loan from the seller.
The deal is expected to close during the first quarter of 2022 subject to the fulfilment of the certain customary conditions.
The White & Case team that advised on the transaction consisted of partner Leonardo Graffi (Milan), Vivian Tsoi (Shanghai) and Alex Zhang (Shanghai & Beijing), local partner Piero de Mattia (Milan) and associates Alessandro Paccoi (Milan), Charlie Zhu and Rita Li (both Shanghai).
For more information please speak to your local media contact.